Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Charles Jonassaint, PhD
Researcher Assistant Professor of Medicine
UPMC Montefiore Hospital
230 McKee Place, Suite 600
Pittsburgh, Pennsylvania, United States
Dr. Jonassaint is a practicing clinical health psychologist with an MHS in cardiovascular epidemiology. He has clinical expertise in chronic disease self-management and cognitive behavioral therapy, and has had extensive experience working with patients from under-represented minority groups. He has primarily focused on working with adolescents and adults living with sickle cell disease (SCD), a condition that disproportionately affects those of African descent and is associated with significant disparities in both funding and treatment.
In Dr. Jonassaint’s research, their group has been working on understanding how mobile phones can be used to improve patient mental health and pain outcomes. He is the co-inventor of an SCD specific self-management app called SMART: The Sickle Cell Disease Mobile Application to Record Symptoms via Technology. Testing of SMART has led to three publications and is now being used in four funded studies at three institutions.
Representative Publications:
Video Links:
SickleShare App Developed by Students Working With Dr. Jonassaint at UPMC
+myBinderRelated Content
-
Nadine Matthie, PhD, RNNadine Matthie is an assistant professor...
-
An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomesOBJECTIVE: To identify characteristics ...
-
Onyinye Onyekwere, MDDr. Onyinye Onyekwere is a pediatric hem...
-
FDA Approves Novel Treatment to Target Abnormality in Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
-
2019 Cure Sickle Cell Initiative Annual Forum: Accelerating Scientific PrioritiesTuesday, November 19 - Thursday, Novembe...
-
Practice variation in emergency department management of children with sickle cell disease who present with feverOBJECTIVES:Urgent medical evaluation is ...
-
PCORI Board Approves $18 Million for Research on Sickle Cell DiseaseThe Patient-Centered Outcomes Research I...
